UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000048934
Receipt No. R000055753
Scientific Title Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.
Date of disclosure of the study information 2022/09/14
Last modified on 2022/09/14 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.
Acronym Analysis of the progress of pancreatic carcinoma in situ.
Scientific Title Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.
Scientific Title:Acronym Analysis of the progress of pancreatic carcinoma in situ.
Region
Japan

Condition
Condition Pancreatic carcinoma in situ
Small pancreatic ductal adenocarcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 Molecular pathological analysis of the occurrence and progress of pancreatic carcinoma in situ using biopsy/pancreatic juice specimen.
Basic objectives2 Others
Basic objectives -Others Comparison of pancreatic cancer in situ cell and resected pancreas specimen
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Analysis of the molecular pathological factor effecting the progress of pancreatic carcinoma in situ.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patients with suspicious pancreatic carcinoma in situ and who undergo pancreatic juice cytology.
Key exclusion criteria cannot obtain consensus.
cannot obtain sufficient pancreatic juice.
cannot undergo surgically resection
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Ryota
Middle name
Last name Sagami
Organization Oita University Faculty of Medicine
Division name Department of Gastroenterology
Zip code 879-5593
Address 1-1 Idaigaoka, Hasamacho, Yufu, Oita 8795593, Japan
TEL 097-549-4411
Email sagami1985@yahoo.co.jp

Public contact
Name of contact person
1st name Ryota
Middle name
Last name Sagami
Organization Oita University Faculty of Medicine
Division name Department of Gastroenterology
Zip code 879-5593
Address 1-1 Idaigaoka, Hasamacho, Yufu, Oita 8795593, Japan
TEL 097-549-4411
Homepage URL
Email sagami1985@yahoo.co.jp

Sponsor
Institute Oita University Faculty of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Oita University Faculty of Medicine
Address 1-1 Idaigaoka, Hasamacho, Yufu, Oita 8795593, Japan
Tel 097-549-4411
Email sagami1985@yahoo.co.jp

Secondary IDs
Secondary IDs YES
Study ID_1 2340
Org. issuing International ID_1 Oita University Faculty of Medicine
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2022 Year 07 Month 25 Day
Date of IRB
2022 Year 07 Month 25 Day
Anticipated trial start date
2022 Year 07 Month 25 Day
Last follow-up date
2027 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2022 Year 09 Month 14 Day
Last modified on
2022 Year 09 Month 14 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055753